The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease

NCT01591187 | Completed

• 1 other identifier: XPD12-026 SMTEXT
• Study Type: observational
• Target: 77
• Locations: 1 country
• Sites: 1

Brief Summary

Exposure to secondhand smoke is a leading preventable cause of child morbidity and mortality, and the adverse health consequences of secondhand smoke are magnified among youngsters with cancer and sickle cell disease. Current methods for measuring secondhand smoke exposure (SHSe) rely on retrospective reports over extended time periods that are subject to recall errors and systematic inaccuracies in reporting and often do not include the youngster as the primary informant. These methods may underestimate the extent of cumulative SHSe and are not well suited to capturing exposure over time and across settings where young people frequent. More appealing methods that engage youngsters to better monitor tobacco smoke in their environment are warranted. The study will examine the feasibility of cell phone texting to obtain measures of secondhand smoke exposure (SHSe) in children treated for cancer or sickle cell disease (SCD).

Conditions

Cancer; Sickle Cell Disease

Keywords

Text messaging; Secondhand smoke exposure

Outcome Measures

Primary Outcomes (1)

• Rate of participation and compliance by disease group

  Rates of participation on the study, compliance with reporting SHSe, feedback about the technical viability of the texting methods, and satisfaction regarding the texting procedures will be obtained.

  at end of 7-day period

Secondary Outcomes (1)

• Parent reports of child SHSe; attitudinal, behavioral, and other socio-environmental variables.

  at end of 90-day period

Study Arms (2)

Cancer

Participants with a diagnosis of cancer.

Sickle Cell Disease

Participants with a diagnosis of sickle cell disease. Interventions: Text messaging, Questionnaire, Interviews

Other: Text messaging; Other: Questionnaire; Other: Interviews

Interventions

Text messaging OTHER

Participants report on the smoking that takes place in their presence for a period of 7 days by responding to daily texted messages sent by the research team to their mobile phones. Parents will also be asked to report on the child's SHSe during the same 7-day period so that child and parent reports can be compared.

Sickle Cell Disease

Questionnaire OTHER

Child and parent questionnaire data about attitudes, behavioral practices to control SHSe, and other socio-environmental factors will be obtained.

Sickle Cell Disease

Interviews OTHER

Individual interviews with youngsters will provide additional qualitative information about the social context and conditions in the child's environment that maintain or contribute to avoidance of exposure.

Sickle Cell Disease

Eligibility Criteria

• Age: 10 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

For the purposes of this protocol, the notation of the term "parent" will be used to include biological parents, step-parents, and legal guardians. The primary study population will consist of patients and parents with the characteristics noted under eligibility criteria.

You may qualify if:

• Child Participant:
• St. Jude Children's Research Hospital (SJCRH) patient with primary diagnosis of any type of cancer or any sickle cell disease genotype (HbSS, HbSC, HbSβ°thal, HbSβ+thal, HbSD, HbSO, Hb S/HPFH, HbSE).
• to \< 18 years of age at the time of enrollment.
• For cancer patients, at least one month from diagnosis and in active treatment section at the time of enrollment.
• Lives in a smoking household defined as at least one adult (\> 18 years) smoker who resides in the home. Smoking adults will be defined as those who have smoked at least one cigarette in the past 30 days, per parent report.
• Does not currently use tobacco (defined as abstinence from tobacco during the 30 days preceding the screening assessment as based on patient and/or parent report).
• Able to demonstrate satisfactory texting skills via mobile phone as determined by study research staff.
• Cannot have significant cognitive or learning impairment that precludes completion of study measures.
• Reads and speaks English.
• Willing and able to provide assent according to institutional guidelines.
• Parent Participant:
• Parent of SJCRH patient who meets criteria as stated above.
• Reads and speaks English.
• Willing and able to provide informed consent according to institutional guidelines.

You may not qualify if:

• Child Participant:
• Patients diagnosed with cancer who have relapsed or have recurrence of disease within the past month or those with progressive disease.
• Patients in medical crisis as determined by consultation with their primary care physician.
• On bone marrow transplant service.
• On inpatient service or expected/scheduled inpatient admission (e.g. hospitalized).
• Acute complications of sickle cell disease requiring hospitalization or an acute care visit including pain crises, acute chest syndrome, acute cerebrovascular events/stroke or active infection/fever.
• Patient is residing in St. Jude long-term nonsmoking housing facility (e.g. Target House or Ronald McDonald House) during the 7-day texting data collection phase.
• Parent participant:
• Cannot be in crisis or distress or have another disabling condition that would preclude participation as determined by review of patient's medical record prior to study enrollment.

Sponsors & Collaborators

• St. Jude Children's Research Hospital: lead
• San Diego State University: collaborator
• University of South Florida: collaborator

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

Related Links

• St. Jude Children's Research Hospital
• Clinical Trials Open at St. Jude

MeSH Terms

Conditions

Neoplasms; Anemia, Sickle Cell

Interventions

Surveys and Questionnaires; Interviews as Topic

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Anemia; Hematologic Diseases; Hemic and Lymphatic Diseases; Hemoglobinopathies; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• James Klosky, PhD

  St. Jude Children's Research Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 1, 2012
• First Posted: May 3, 2012
• Study Start: May 1, 2012
• Primary Completion: June 1, 2014
• Study Completion: November 1, 2014
• Last Updated: March 5, 2015

Record last verified: 2015-03

Locations

US (1)